- Monday night, Tekmira Pharmaceuticals (TSE:TKM) (NASDAQ:TKMR) announced that it reached a litigation settlement with Alnylam Pharmaceuticals (NASDAQ:ALNY) and will receive $65 million from Alnylam within ten days, … Continue Reading
Read nowResearch - It was just over one year ago that Tekmira Pharmaceuticals (TKMR) changed its name to Arbutus Biopharma (ABUS), and its focus to HBV, moving away from … Continue Reading
Read nowResearch - The recovery is slowly underway in the land of biotech, and these equities are getting a lift from Pfizer's (PFE) planned merger with Allergan (AGN), announced Monday.
Read nowResearch - What a crazy end of summer. Thankfully, today’s the first day of Fall. We’ve got a bunch of updates – insights and administrative – for … Continue Reading
PremiumInsights - To say that Biogen (BIIB) disappointed in a big way on Friday would be an understatement. With its second quarter earnings release on Friday morning … Continue Reading
Read nowzPremium - Greece unknowns weigh on the market going into the holiday weekend (Happy fourth by the way!), but the referendum on Sunday should offer some perspective … Continue Reading
PremiumRecap - After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.4%, the lowest since 2008, and a … Continue Reading
Read now
